Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.

Report: Partnering Deals and Alliances with Gilead Sciences

Gilead Sciences is a top pharmaceutical company based in California, USA.

The company was founded in 1987.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.

Since its inception in 1987, the company has primarily concentrated on antiviral drugs to treat patients infected with HIV, hepatitis B, or influenza.

In 2006, Gilead completed two acquisitions that allowed the company to branch out from its historical antiviral franchise into the cardiovascular and respiratory therapeutic arenas.

The company has always focused on advancing innovations that provide better options and outcomes, enabling healthier lives.

Gilead Sciences has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. Gilead has a long history of partnering, building numerous collaborative partnerships more

Gilead Sciences announced over 64 partnering / licensing deals since 2005, with over 20 deals in 2006 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in antivirals, cardiovascular, cancer, followed respiratory and liver diseases more

Gilead Sciences has also announced over 9 M&A deals since 2005, with the lead deals being the acquisition of Myogen, Inc. for $2.5 Billion and Corus Pharma for $365 Million which marked the entry of Gilead in cardiovascular and respiratory markets more

Report: Partnering Deals and Alliances with Gilead Sciences

Examples of recent partnering and licensing deals announced by Gilead Sciences can be viewed in Current Partnering’s Partnering Agreements with Gilead Sciences 2005-2013 activity review article.

Examples of recent M&A deals announced by Gilead Sciences can be viewed in Current Partnering's Partnering Deals and Alliances with Gilead Sciences activity review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Gilead Sciences

See also

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Gilead Sciences

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for Gilead Sciences

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Gilead Sciences company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk